Physician profile
Alyse M Kelly Jones
NPI 1558367680
$377,321.04
in general payments reported to CMS, 2019-2025
46 companies · $136K in 2025
The $136K reported for 2025 was more than what 99% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $8,090 · 2021: $13K · 2022: $21K · 2023: $104K · 2024: $79K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $218K · Travel and Lodging: $61K · Food and Beverage: $15K · Consulting Fee: $13K · Honoraria: $12K · Education: $99.00 · Gift: $3.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $218,223.50 |
| Travel and Lodging | $60,775.78 |
| Food and Beverage | $15,267.11 |
| Consulting Fee | $13,475.00 |
| Honoraria | $12,150.00 |
| Education | $99.00 |
| Gift | $3.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $242,141.21 | 2020-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $72,255.87 | 2022-2025 | |
| Myovant Sciences INC. | $20,855.21 | 2021-2022 | |
| Therapeuticsmd, INC. | $8,627.12 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $8,249.57 | 2019 | |
| Exact Sciences Corporation | $7,192.28 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $4,782.04 | 2023-2025 | Myfembree, Gemtesa |
| Ascend Therapeutics US, LLC | $2,107.38 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,094.14 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $2,072.70 | 2024 | Xiaflex |
| Abbvie INC. | $1,616.52 | 2020-2025 | |
| Scynexis, INC. | $1,185.74 | 2021-2022 | |
| Lupin INC. | $660.01 | 2020-2021 | |
| Agile Therapeutics, INC. | $438.00 | 2023 | Twirla |
| Pfizer INC. | $399.05 | 2021-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $350.55 | 2019-2025 | Wegovy |
| Idorsia Pharmaceuticals US INC | $261.19 | 2023-2024 | Quviviq |
| Avion Pharmaceuticals | $199.77 | 2020-2022 | |
| Cosette Pharmaceuticals INC. | $191.73 | 2025 | Vyleesi |
| Hologic Sales and Service, LLC | $160.23 | 2021-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Organon LLC | $154.57 | 2022-2025 | Nexplanon |
| Millicent US INC | $139.10 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $132.98 | 2022-2025 | Slynd |
| Lilly USA, LLC | $122.73 | 2023-2025 | Zepbound |
| Vivus LLC | $113.35 | 2024-2025 | Pancreaze, Qsymia |
| Evofem Biosciences, INC. | $108.25 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mycovia Pharmaceuticals, INC. | $102.71 | 2022-2023 | Vivjoa |
| Shield Therapeutics INC | $93.98 | 2023-2024 | Accrufer |
| Mylan Pharmaceuticals INC. | $81.61 | 2022 | |
| Medtronic, INC. | $43.70 | 2023 | Ligasure |
| Coopersurgical, INC. | $42.10 | 2020-2023 | Paragard T 380a |
| Aspira Women'S Health INC | $32.18 | 2024 | Ova1 |
| Virtus Pharmaceuticals LLC | $30.86 | 2021 | |
| Amgen INC. | $29.92 | 2023-2024 | Prolia, Evenity |
| Gynesonics, INC. | $29.87 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Tactile Systems Technology INC | $26.54 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $24.10 | 2022 | |
| Ethicon US, LLC | $22.15 | 2020 | |
| Sage Therapeutics, LLC | $22.01 | 2024 | |
| Verity Pharmaceuticals INC. | $21.73 | 2024 | Tlando |
| Abbott Laboratories | $19.81 | 2025 | Alinity M |
| Merck Sharp & Dohme LLC | $19.39 | 2024 | Gardasil 9, Gardasil |
| Janssen Pharmaceuticals, INC | $17.84 | 2024 | Spravato |
| Biohaven Pharmaceuticals, INC. | $17.72 | 2021 | |
| Medtronic USA, INC. | $16.53 | 2020 | |
| Currax Pharmaceuticals LLC | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyse Kelly Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.